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ABSTRACT
Background and Objective: Reports on MRSA strains are increasing worldwide. The aim of this study was to find the 
prevalence of MRSA strains isolated from clinical specimens and to evaluate their resistance profile. Additionally we 
compared the phenotypic and genotypic methods for detection of methicillin resistance.  
Materials and Methods: In this cross-sectional study, a total of 41 isolates of S. aureus were collected from clinical 
specimens at two teaching hospitals in Ardabil, Iran. All isolates were identified at the species level by standard biochemical 
tests. The methicillin resistance were evaluated using three methods: PCR for mecA gene, agar dilution for determination 
of oxacillin MIC and disk diffusion test to detect methicillin, oxacillin and cefoxitin resistance. Antimicrobial resistance 
patterns were determined by disk diffusion method.
Results: The results identified 19 (46.3 %) out of 41 isolates as MRSA. Most of the MRSA strains (68.4%) were isolated 
from patients hospitalized in ICU. All isolates were susceptible to vancomycin, mupirocin and linezolid. Among other 
antibiotics co-trimoxazole was more active against MRSA isolates. Using PCR as reference method all the phenotypic tests 
showed 100% specificity. The sensitivity for MIC test and cefoxitin was 100% and for methicillin and oxacillin disks was 
77.7% and 89.5%, respectively. 
Conclusion:  The prevalence of MRSA strains in our hospitals especially in ICU ward was high and disk diffusion testing 
using cefoxitin or oxacillin MIC test as an alternative to PCR for detection of MRSA is recommended.
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INTRODUCTION
Staphylococcus aureus is one of the most important 
and frequent cause of nosocomial infections 
worldwide (1). Emergence of methicillin-resistant S. 
aureus strain (MRSA) in 1961 made staphylococcal 
infections as a major therapeutic challenge (2). 
Initially MRSA infections were observed in 
hospitalized patients and those with chronic illnesses. 
These types of infections are caused by strains named 
as hospital-associated MRSA (HA-MRSA) (3). In 
1990s another type of MRSA strain was emerged 
that primarily causes skin and soft tissue infections 
in healthy people. It is called community-associated 
MRSA (CA-MRSA) (3). MRSA strains show 
distinct microbiological, therapeutic and clinical 
features compared to their methicillin-susceptible 
(MSSA) counterparts. From microbiological aspect, 
HA-MRSA strains are resistant to multiple classes 
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of antibiotics. This characteristic limits proper 
therapeutic options against staphylococcal infections 
(4). Clinically, infections caused by HA-MRSA strains 
are associated with higher mortality and morbidity 
(5). Some CA-MRSA strains express additional 
virulence factors that enable them to causes more 
serious diseases (6). 
Currently, MRSA strains account for many of 
staphylococcal infections and reports of MRSA strains 
are increasing worldwide (7). There are also several 
reports from Iran showing the prevalence of methicillin 
resistance among clinical isolates of S. aureus (8-11). 
A meta-analysis study recently carried out in Iran by 
Askari et al., showed that the average prevalence rate 
of  MRSA isolates among clinical specimens were 
52.7% (12). Understanding the prevalence, antibiotic 
resistance patterns and information on accurate and 
reliable detection methods of MRSA strains are 
necessary for appropriate antibiotic treatment and 
effective infection control. Considering these, the 
current study was performed to find the prevalence 
and evaluate the antimicrobial resistance profile of 
MRSA strains isolated from clinical specimens in 
Ardabil, the northwest region of Iran. Additionally 
we compared the phenotypic and genotypic methods 
for detection of methicillin resistance.
MATERIALS AND METHODS
Bacterial Isolates. From July to December 2011, 
a total of 41 S. aureus isolates were collected from 
patients admitted to two teaching hospitals affiliated 
to Ardabil University of Medical Sciences. Isolates 
were examined by conventional methods such as 
colony morphology on blood agar, Gram stain 
characteristics and catalase production then identified 
as S. aureus by tube coagulase and DNase tests. 
Identified strains were stored at -80ºC in Mueller-
Hinton broth containing 15% glycerol.
Determination of methicillin resistance. Methicillin 
resistance was evaluated using three methods: 1) 
Disk diffusion test using 30  µg cefoxitin disk (≤ 21 
mm indicated MRSA), 1  µg oxacillin disk (≤ 10 mm 
indicated MRSA), and 5  µg methicillin disk (≤ 9 
mm indicated MRSA); 2) Oxacillin MIC (Minimum 
Inhibition Concentration) test (≥ 4  µg/ml indicated 
MRSA); and 3) Polymerase chain reaction (PCR) 
for the detection of mecA gene (positive indicated 
MRSA) (13,14). Antibiotic disks were obtained from 
Himedia (Himedia Laboratories, Pvt. Ltd., Mumbai, 
India) and oxacilllin powder for MIC determination 
was purchased from Sigma-Aldrich (St. Louis, MO, 
USA). All tests were compared for sensitivity and 
specificity with PCR for mecA gene as reference 
method. Sensitivity was calculated by dividing 
the number of mecA-positive isolates detected as 
resistant using phenotypic methods by the total 
number of mecA-positive strains (ether susceptible or 
resistant). Specificity was calculated through dividing 
the number of mecA-negative isolates classified as 
sensitive based on phenotypic criteria by the total 
number of mecA-negative isolates (15). 
Antimicrobial susceptibility testing. The isolates 
were tested for antibiotic sensitivity using  the Kirby 
Bauer disk diffusion method by employing the 
following disks (disk); penicillin (10) co-amoxiclav 
(30), chloramphenicol (30), tetracycline (30), 
ciprofloxacin (10), ceftriaxone (100), cefazolin (30), 
clindamycin (2),   imipenem (10), co-trimoxazole (25), 
rifampicin (30), gentamicin (10) pristinamycin (15), 
linezolid (30) and mupirocin (5). MICs of oxacillin 
and vancomycin to the both MRSA and MSSA 
isolates were determined by agar dilution method. All 
procedures were carried out and interpreted according 
to CLSI guideline (13). S. aureus ATCC 25923, ATCC 
29213 and ATCC 33591 were used as control strains in 
disk diffusion and agar dilution methods.
PCR amplification of mecA gene. Total bacterial 
DNA was extracted from S. aureus using 
DNP™ Genomic DNA Extraction Kit (Cinagen, 
Tehran, Iran). Oligonucleotide primers (14): 
 5’- AAAATCGATGGTAAAGGTTGGC-3’ (forward) 
and 5’- AGTTCTGCAGTACCGGATTTGC-3’ (revers) 
were synthesized by Bioneer company (Daejon, South 
Korea). PCR was performed in a 20 × µL AccuPower™ 
PCR PreMix (Bioneer) with 10 pmol of each primers 
under the following conditions: initial denaturation at 
95°C for 5 min, followed by 34 cycles of 95°C for 1 
min, 55°C for 1 min and 72°C for 1 min, and a final 
incubation at 72°C for 5 min. The amplified DNA 
fragments (PCR product: 533 bp) were separated on 
1% (w/v) agarose gel, stained with ethidium bromide 
and visualized under ultraviolet light. S. aureus ATCC 
29213 and ATCC 33591were used as mecA negative 
and positive controls respectively.
Statistical analysis. Chi-square test was used to 
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compare the prevalence of MRSA and MSSA strains 
between specimen type and hospital wards.
RESULTS
A total of 41 non duplicate S. aureus isolates 
including 22 (53.6%) MSSA and 19 (46.3%) MRSA 
were isolated from different clinical specimens that 
have been sent to the Microbiology Laboratory. 
The prevalence of MRSA was significantly higher 
(P = 0.0001) in sputum (n = 11, 57.8%) than other 
specimens respectively (Table 1). The majority of 
isolates with MSSA phenotype were cultured from 
urine specimens (n = 9, 40.9%). 
  Table 2 shows the distribution of isolate in 
relationship with hospital wards. The prevalence of 
MRSA isolates (68.4%) were significantly higher 
(P = 0.0001) in patients from intensive care unit 
(ICU). MRSA accounted for about 81.25% of S. 
aureus strains from patients at ICU.
The MICs for oxacillin and vancomycin are listed 
in Table 3. The MICs for oxacillin were between 
64  to ≥ 512  µg/mL and ≤ 0.25  to 1  µg/mL for 
MRSA and MSSA strains respectively. The MICs for 
vancomycin against both MRSA and MSSA strains 
were 1  µg/mL. Only, 1 MRSA strain showed MIC 
equal to 2  µg/mL. These strains did not fall into 
vancomycin resistant category according to CLSI (13). 
Table 4 represents the resistance pattern of S. aureus 
isolates (MRSA and MSSA) to the tested antibiotics. In 
this study the entire S. aureus isolates were susceptible 
to vancomycin, mupirocin and linezolid. Among other 
antibiotics imipenem and co-trimoxazole showed to be 
the most effective antibiotics against MRSA isolates. 
PCR testing revealed the presence of mecA gene in all 
isolates (Fig 1) which were determined as methicillin 
resistant by the phenotypic methods. The sensitivities 
of oxacillin MIC test and cefoxitin disk were 100%, 
whereas the sensitivities of methicillin and oxacillin 
disks were 77.7% and 89.5% respectively. 
METHICILLIN RESISTANT SATPHYLOCOCCUS AUREUS IN ARDABI
Table 1. Prevalence of S. aureus among clinical specimens in relationship with specimen type.
Specimen type MSSA  n (%) MRSA n (%) Total
Sputum 6 (27.3) 11 (57.8) 17
Blood 6 (27.3) 3 (15.7) 9
Urine 9 (40.9 ) 1(5.2) 10
Wound 1 (4.5) 3 (15.7) 4
Cerebral spinal fluid - 1(5.2) 1
Total 22 (100) 19 (100) 41
Table 2. Prevalence of S. aureus among clinical specimens in relationship with hospital wards.
Ward MSSA n (%) MRSA n (%)
Emergency 2 (13.3) 2 (11.1)
Surgery 1 (6.6) 3 (16.6)
Infectious 4 (26.6) -
Intensive care unit 3 (20) 13 (68.4)
Outpatient (Clinic) 4 (26.6) -
Total 22 (100) 19 (100)
Table 3. Frequency and range of oxacillin and vancomycin MICs of S. aureus (MRSA and MSSA) isolated from clinical 
specimens by agar dilution method.
 MIC
µg/ml
Oxacillin MIC  
µg/ml
Vancomycin
MRSA, n (%) MSSA, n (%) MRSA, n (%) MSSA, n (%)
≤ 0.25 - 14 (63.6) 1 18 (94.7) 22 (100)
0.5 - 2 (9) 2 1 (5.3) -
1 - 6 (27.2)
64 2 (25)
128 1(12.5 )
≥ 512  16 (62.5)
166           IRAN. J. MICROBIOL. Vol. 6, No. 3 (June 2014), 163-168           http://ijm.tums.ac.ir
DISCUSSION
Since the emergence of MRSA in 1961, there 
has been a steady increase in the prevalence of this 
type of S. aureus strains worldwide (7). Currently, 
more than 50% of S. aureus infections are caused 
by MRSA strains in the US (3).  The reports from 
Iran also indicate the increasing incidence of MRSA 
in clinical specimens over the time (8-12). In this 
study out of 41, 19 (46.3%) of isolates were MRSA 
strains. Worldwide, HA-MRSA prevalence varies 
considerably, from <1 percent in Scandinavia to 
>50 percent in other countries (7). The estimated 
prevalence in our study locates in upper limits of 
the reported ranges. However there is not a uniform 
prevalence reported for MRSA infection in the 
different studies. The heterogeneity is probably due 
to applying different infection control measures, 
antibiotic administration, human population, study 
design and laboratory testing for determining 
methicillin resistance (12). In this study methicillin 
and oxacillin disks could not detect all MRSA isolates 
but cefoxitin disk and oxacillin MIC test showed the 
sensitivity equal to PCR. These results are similar to 
the previous reports (16). However, the emergence 
of mecA positive oxacillin susceptible and mecA 
negative oxacillin resistant–MRSA strains reduces 
the sensitivities of both the phenotypic and genotypic 
methods (17-19). Thus, combination of genotypic and 
phenotypic tests is necessary to detect the methicillin 
resistance in S. aureus accurately. 
MRSA infections pose a significant concern for 
ICU patients (19). In this study, the incidence rate 
of MRSA infection in ICU patients was significantly 
higher than other wards, with an estimated prevalence 
as high as 68.4% and within ICU MRSA strains were 
responsible for about 81% of S. aureus infections. 
Previously it has been documented that MRSA 
accounted for 57% of all ICU acquired S. aureus 
infections (19). However, recent reports indicate 
declining ICU acquired MRSA infections with 
applying appropriate infection control measures, 
rapid and reliable detection of methicillin resistance 
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Fig1. PCR detection of mecA gene among S. aureus 
isolates. Lane M: 50 pb DNA size marker, Lane 1: positive 
control strain ATCC 33591. Lane 2: negative control strain 
ATCC 29213. Lanes 3, 5, 6 and 9 mecA positive isolates. 
Lanes: 4, 7 and 8 mecA negative isolates.
Table 4. Antibiotic susceptibility profiles of S. aureus strains isolated from clinical specimens by disk diffusion method.
   
 Antibiotic
MSSA (N = 22), n (%) MRSA (N = 19), n (%)
Susceptible Intermediate Resistant Susceptible Intermediate Resistant
Vancomycina 22 (100) - - 19 (100) - -
Penicillin 6 (27.2) - 16 (72.7) - - 19 (100)
Co-amoxiclav 10 (45.4) - 12 (54.5) 2 (10.5) - 17 (89.4)
Chloramphenicol 22 (100) - - - - 19 (100)
Tetracycline 20 (90.9) - 2 (9) 3 (15.7) 16 (84.2)
Ciprofloxacin 22 (100) - - 1 (5.2) 5 (26.3) 13 (68.4)
Ceftriaxone 16 (72.7) 6 (27.2) - 2 (10.5) - 17 (89.4)
Cefazolin 21 (95.4) - 1 (4.5) 3 (15.7) 1 (5.2) 15 (78.9)
Clindamycin 20 (90.9) - 2 (9) 1 (5.2) - 18 (94.7)
Imipenem 22 (100) - - 14 (73.6) 3 (15.7) 2 (10.5)
Co-trimoxazole 18 (81.8) 1 (4.5) 3 (13.6) 17 (89.4) - 2 (10.5)
Erythromycin 20 (90.9) - 2 (9) 3 (15.7) - 16 (84.2)
Gentamicin 22 (100) - - 4 (21) - 15 (78.9)
Rifampicin 22 (100) - - 3 (15.7) - 16 (84.2)
Pristinamycin 18 (81.8) 1 (4.5) 3 (13.6) 5 (26.3) - 14 (73.6)
Linezolid 22 (100) - - 19 (100) - -
Mupirocin 22 (100) - - 19 (100) - -
a. Vancomycin susceptibility profile was determined using agar dilution method. 
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and effective antibiotic therapy (2, 20).
In this study, all isolates were susceptible to 
vancomycin, mupirocin, linezolid. The absence of 
resistance to mupirocin may be related to the low 
usage of this antibiotic in the study setting. However 
others have recently reported the incidence of high-
level mupirocin resistant S. aureus strains isolated 
from patients in Iran (11). Mupirocin is topical agent 
often used to eradicate nasal carriage and control 
outbreaks of methicillin-resistant S. aureus (11). 
The vancomycin is the drug of choice for the 
treatment of infections due to MRSA (21). Several 
studies reported emergence of vancomycin resistant 
clinical MRSA isolates around the world (22-24). 
In our study all of the isolates displayed MICs of 
≤ 2 µg/ml to vancomycin and were susceptible to 
vancomycin.
Multiple-drug resistant characteristics of MRSA 
and emergence of glycopeptide resistant strains 
have been frequently caused treatment failure of 
MRSA infections (25). These findings have promoted 
researchers to seek new antibiotics for the treatment 
of MRSA infections (26). Linezolid and pristinamycin 
showed good activity in vitro and in vivo and are 
promising therapeutic options against staphylococcal 
infections (27-28). In this study all isolates were 
susceptible to linezolid. Similar to our previous study 
on S. aureus strains isolated from health care workers 
in the same setting (15), 3 (13.6%) MSSA and 14 
(73.6%) MRSA strains were found to be resistant to 
pristinamycin. This antibiotic is not generally used in 
Iran for treatment of bacterial infectious. Therefore, 
emergence of pristinamycin resistant S. aureus 
strains in our hospitals could be surprising. There 
is also a similar finding that has been reported from 
India (29). Some previous studies demonstrated that 
antimicrobial selective pressure and microbial cross-
transmission are involved in pristinamycin resistance 
acquisition in S. aureus (30). 
The high resistance rate for most commonly used 
antibiotics was observed among MRSA isolates in 
comparison to MSSA. Most of the MRSA strains 
were resistant against multiple classes of commonly 
used antibiotics. Except for above mentioned 
antibiotics, co-trimoxazol and imipenem showed the 
lowest resistance rate for MRSA isolates. However, 
MRSA strains should be considered as resistant to 
all β-lactam agents other than the cephalosporins 
with anti-MRSA activity as stated by CLSI (13). 
Resistance of MRSA to co-trimoxazol in general is 
low. Several studies reported a decrease in resistance 
of MRSA to co-trimoxazol over the time (31-32). 
In conclusion, the frequency of MRSA infection in 
our hospitals was found to be high and this finding 
highlights the need for applying appropriate infection 
control measures and effective antibiotic therapy. 
Moreover results emphasize the use of cefoxitin 
disk diffusion or oxacillin MIC tests as accurate 
phenotypic methods in clinical laboratories if PCR 
for mecA gene detection is not feasible.
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